836620-48-5 Usage
Uses
Used in Pharmaceutical Industry:
AS1842856 is used as a FoxO1 antagonist for its anti-obesity effects and potential treatment of type 2 diabetes mellitus (T2DM). By inhibiting FoxO1-mediated transactivation, it can decrease the expression of G6Pase and PEPCK mRNA, and inhibit glucogenesis, making it a promising candidate for the development of therapeutic agents targeting obesity and T2DM.
Check Digit Verification of cas no
The CAS Registry Mumber 836620-48-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,6,6,2 and 0 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 836620-48:
(8*8)+(7*3)+(6*6)+(5*6)+(4*2)+(3*0)+(2*4)+(1*8)=175
175 % 10 = 5
So 836620-48-5 is a valid CAS Registry Number.
836620-48-5Relevant articles and documents
QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME
-
Paragraph 00770; 00783-00784, (2020/08/22)
The present disclosure relates to quinolin-4-one and 4(1H)-cinnolinone compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells, including inducing the stem/progenitor cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into tissue cells.
QUINOLONE DERIVATIVE OR SALT THEREOF
-
Page/Page column 24; 26, (2008/06/13)
A platelet aggregation inhibitor comprising a quinolone derivative or a pharmaceutically acceptable salt thereof as an active ingredient, and a novel quinolone derivative or a pharmaceutically acceptable salt thereof useful as a platelet aggregation inhibitor.
